ADMA BIOLOGICS INC (ADMA)
US0008991046 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -3.64M | -28.24M | -65.90M | -71.65M | -75.75M | |||
| Depreciation Amortization | 8.42M | 8.33M | 7.11M | 5.50M | 3.94M | |||
| Change In Working Capital | -22.11M | -10.12M | -18.29M | -51.68M | -33.78M | |||
| Interest Paid | 13.99M | 18.05M | 13.88M | 11.16M | 10.27M | |||
| Other non cash items | 38.65M | 38.83M | 17.57M | 5.46M | 3.58M | |||
| OPERATING CASH FLOW | 21.30M | 8.80M | -59.51M | -112.37M | -102.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -5.40M | -4.98M | -13.91M | -13.51M | -12.73M | |||
| Other Investing Activity | N/A | N/A | N/A | 0.00 | 0.00 | |||
| INVESTING CASH FLOW | -5.40M | -4.98M | -13.91M | -13.51M | -12.72M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -23.59M | -23.60M | 51.71M | -30.00K | 13.52M | |||
| Stock Issued/Repurchased | N/A | 1.10M | 64.82M | 121.14M | 131.21M | |||
| Other Financing Activity | -18.33M | -16.49M | -7.68M | -60.00K | -830.00K | |||
| FINANCING CASH FLOW | -39.79M | -38.99M | 108.85M | 121.05M | 143.90M | |||
| CHANGE IN CASH | -23.89M | -35.17M | 35.43M | -4.83M | 29.18M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 21.30M | 8.80M | -59.51M | -112.37M | -102.00M | |||
| Capital Expenditure | -5.40M | -4.98M | -13.91M | -13.51M | -12.73M | |||
| FREE CASH FLOW | 15.90M | 3.82M | -73.42M | -125.88M | -114.73M | |||
All data in USD